Hsian-Rong Tseng

Dr. Hsian-Rong Tseng is a Professor at the David Geffen School of Medicine, University of California, Los Angeles (UCLA), with joint appointments at the California NanoSystems Institute, Crump Institute for Molecular Imaging, and Jonsson Comprehensive Cancer Center. His research focuses on developing nanotechnology-enabled solutions for cancer diagnostics and therapeutics, particularly in hepatocellular carcinoma (HCC), pancreatic cancer, and prostate cancer, leveraging extracellular vesicles, liquid biopsy techniques, and CRISPR-based gene editing.

• Affiliation with California NanoSystems Institute
• Joint membership in Crump Institute for Molecular Imaging
• Member of Jonsson Comprehensive Cancer Center

Research interests include nanotechnology for noninvasive cancer detection, gene therapy for genetic disorders, and liquid biopsy applications to monitor treatment responses and disease progression. His work integrates click chemistry, supramolecular nanoparticles, and digital scoring assays to isolate and analyze circulating tumor cells and extracellular vesicles.

Recent publications highlight trends in extracellular vesicle purification, RNA sequencing for early cancer detection, and CRISPR/Cas9 knockin strategies targeting β-hemoglobinopathies and retinoschisis. Articles emphasize noninvasive diagnostics, biomarker discovery, and personalized monitoring of cancers like HCC, pancreatic ductal adenocarcinoma, and prostate cancer.

• Yong Ju | Postdoc | yju@mednet.ucla.edu
• Hyoyong Kim | Postdoc | hyoyongkim@mednet.ucla.edu
• Junseok Lee, Ph.D. | Researcher | junseoklee@mednet.ucla.edu